ApprovalTrail

Company · Brampton, Ontario, Canada

Sun Pharma Canada Inc.

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
169
158 authorized now
Natural health products
9
9 active licences
Medical device licences
0
0 active
Notices of Compliance
165

Drug products

Authorized products first.

NameDINStatus
SPC-ATORVASTATINStatus since Jul 202602313707Marketed
SPC-ATORVASTATINStatus since Jul 202602313715Marketed
SPC-ATORVASTATINStatus since Jul 202602313723Marketed
SPC-ATORVASTATINStatus since Jul 202602313758Marketed
SPC-CEFPROZILStatus since Jun 202502293528Marketed
SPC-CEFPROZILStatus since Jun 202502293536Marketed
SPC-CEFPROZILStatus since Oct 202502293579Marketed
SPC-CEFPROZILStatus since Oct 202502329204Marketed
SPC-CLOPIDOGRELStatus since Sep 202602379813Marketed
SPC-DESVENLAFAXINEStatus since Sep 202602532158Marketed
SPC-DESVENLAFAXINEStatus since Sep 202602532166Marketed
SPC-ESCITALOPRAMStatus since Mar 202602385481Marketed
SPC-ESCITALOPRAMStatus since Mar 202602385503Marketed
SPC-EZETIMIBEStatus since Mar 202602419548Marketed
SPC-FENOFIBRATE EStatus since Nov 202502454696Marketed
SPC-IRBESARTANStatus since Jun 202602406810Marketed
SPC-IRBESARTANStatus since Jun 202602406829Marketed
SPC-IRBESARTANStatus since Jun 202602406837Marketed
SPC-MONTELUKASTStatus since Apr 202502389517Marketed
SPC-PANTOPRAZOLEStatus since Oct 202502305046Marketed
SPC-ROPINIROLEStatus since Jun 202502314037Marketed
SPC-ROPINIROLEStatus since Jun 202502314053Marketed
SPC-ROPINIROLEStatus since Jun 202502314061Marketed
SPC-ROPINIROLEStatus since Jun 202502314088Marketed
SPC-ROSUVASTATINStatus since Oct 202602382644Marketed
SPC-ROSUVASTATINStatus since Oct 202602382652Marketed
SPC-ROSUVASTATINStatus since Oct 202602382660Marketed
SPC-ROSUVASTATINStatus since Oct 202602382679Marketed
TARO-APIXABANStatus since Sep 202202510464Marketed
TARO-APIXABANStatus since Sep 202202510472Marketed
TARO-ATENOLOLStatus since Jan 202002267985Marketed
TARO-ATENOLOLStatus since Jan 202002267993Marketed
TARO-ATENOLOLStatus since Jan 202002373963Marketed
TARO-BUPROPION XLStatus since Feb 202102475804Marketed
TARO-BUPROPION XLStatus since Feb 202102475812Marketed
TARO-CANDESARTANStatus since Mar 202002380684Marketed
TARO-CANDESARTANStatus since Mar 202002380692Marketed
TARO-CANDESARTANStatus since Mar 202002380706Marketed
TARO-CANDESARTANStatus since Mar 202002380714Marketed
TARO-CIPROFLOXStatus since Mar 202002303728Marketed
TARO-CIPROFLOXStatus since Mar 202002303736Marketed
TARO-CIPROFLOXStatus since Mar 202002303744Marketed
TARO-CLARITHROMYCINStatus since May 202402361426Marketed
TARO-CLARITHROMYCINStatus since Mar 202402361434Marketed
TARO-CYPROTERONE/ETHINYL ESTRADIOLStatus since Aug 202002425017Marketed
TARO-DOMPERIDONEStatus since Nov 202102268078Marketed
TARO-DONEPEZILStatus since Mar 202002381508Marketed
TARO-DONEPEZILStatus since Mar 202002381516Marketed
TARO-ENALAPRILStatus since Feb 202202352230Marketed
TARO-ENALAPRILStatus since Feb 202202352249Marketed
TARO-ENALAPRILStatus since Feb 202202352257Marketed
TARO-ENALAPRILStatus since Feb 202202352265Marketed
TARO-ESOMEPRAZOLEStatus since Mar 202202423979Marketed
TARO-ESOMEPRAZOLEStatus since Mar 202202423987Marketed
TARO-GLICLAZIDE MRStatus since Feb 202102439328Marketed
TARO-GLICLAZIDE MRStatus since Feb 202102463571Marketed
TARO-IMIPENEM-CILASTATINStatus since May 202102351706Marketed
TARO-LANSOPRAZOLEStatus since Apr 202102402610Marketed
TARO-LANSOPRAZOLEStatus since Apr 202102402629Marketed
TARO-MEROPENEMStatus since Jun 202102421518Marketed
TARO-MEROPENEMStatus since Jun 202102421526Marketed
TARO-METHYLPHENIDATE ERStatus since May 202602539004Marketed
TARO-METHYLPHENIDATE ERStatus since May 202602539012Marketed
TARO-METHYLPHENIDATE ERStatus since May 202602539020Marketed
TARO-METHYLPHENIDATE ERStatus since May 202602539039Marketed
TARO-PRAVASTATINStatus since Dec 202202284421Marketed
TARO-PRAVASTATINStatus since Dec 202202284448Marketed
TARO-PRAVASTATINStatus since Dec 202202284456Marketed
TARO-PREGABALINStatus since Jun 202002392801Marketed
TARO-PREGABALINStatus since Jun 202002392828Marketed
TARO-PREGABALINStatus since Jun 202002392836Marketed
TARO-PREGABALINStatus since Jun 202002392844Marketed
TARO-PREGABALINStatus since Jun 202002392852Marketed
TARO-PREGABALINStatus since Jun 202002392860Marketed
TARO-RAMIPRILStatus since Feb 202002310503Marketed
TARO-RAMIPRILStatus since Feb 202002310511Marketed
TARO-RAMIPRILStatus since Feb 202002310538Marketed
TARO-RAMIPRILStatus since Feb 202002310546Marketed
TARO-RAMIPRIL HCTZStatus since Nov 202302449439Marketed
TARO-RAMIPRIL HCTZStatus since Dec 202302449447Marketed
TARO-RAMIPRIL HCTZStatus since Dec 202302449455Marketed
TARO-RAMIPRIL HCTZStatus since Dec 202302449463Marketed
TARO-RAMIPRIL HCTZStatus since Nov 202302449471Marketed
TARO-SIMVASTATINStatus since Jan 202002329131Marketed
TARO-SIMVASTATINStatus since Jan 202002329158Marketed
TARO-SIMVASTATINStatus since Jan 202002329166Marketed
TARO-SIMVASTATINStatus since Jan 202002329174Marketed
TARO-SIMVASTATINStatus since Jan 202002329182Marketed
TARO-SOLIFENACINStatus since Dec 201902437988Marketed
TARO-SOLIFENACINStatus since Dec 201902437996Marketed
TARO-TADALAFILStatus since Mar 202402452073Marketed
TARO-TADALAFILStatus since Mar 202402452111Marketed
TARO-TRAMADOL/ACETStatus since Oct 202102388197Marketed
TARO-VALSARTANStatus since Aug 202102363062Marketed
TARO-VALSARTANStatus since Aug 202102363100Marketed
TARO-VALSARTANStatus since Aug 202102363119Marketed
TARO-VENLAFAXINE XRStatus since Oct 202002380072Marketed
TARO-VENLAFAXINE XRStatus since Oct 202002380080Marketed
TARO-VENLAFAXINE XRStatus since Oct 202002380099Marketed
DOMPERIDONEStatus since Sep 202402408937Approved
IBUPROFEN PLUS ACETAMINOPHENStatus since Sep 202602571420Approved
PANTOPRAZOLEStatus since Dec 202202415232Approved
PANTOPRAZOLEStatus since Dec 202202415240Approved
RAN-CLARITHROMYCINStatus since Jun 202202387107Approved
RAN-CLARITHROMYCINStatus since Jun 202202387115Approved
RBX-CLOPIDOGRELStatus since Nov 202202392755Approved
SPC-ESTRADIOL 10Status since Aug 202602570777Approved
SPC-GANIRELIXStatus since Jun 202602569353Approved
SPC-MINOCYCLINEStatus since Jan 202602390124Approved
SPC-MINOCYCLINEStatus since Jan 202602390132Approved
SPC-ROPINIROLEStatus since Jun 202502314045Approved
SPC-VISMODEGIBStatus since Sep 202602571978Approved
TARO-AMLODIPINEStatus since Jul 202502321858Dormant
TARO-AMLODIPINEStatus since Jul 202502321866Dormant
TARO-AMPHETAMINE XRStatus since Mar 202102513889Approved
TARO-AMPHETAMINE XRStatus since Mar 202102513897Approved
TARO-AMPHETAMINE XRStatus since Mar 202102513900Approved
TARO-AMPHETAMINE XRStatus since Mar 202102513919Approved
TARO-AMPHETAMINE XRStatus since Mar 202102513927Approved
TARO-AMPHETAMINE XRStatus since Mar 202102513935Approved
TARO-CLARITHROMYCIN XLStatus since Jun 202202410036Approved
TARO-CLINDAMYCINStatus since Jun 202202391643Approved
TARO-CLINDAMYCINStatus since Jun 202202391651Approved
TARO-IMATINIBStatus since Apr 202302428318Approved
TARO-IMATINIBStatus since Apr 202302428326Approved
TARO-IMIPENEM-CILASTATINStatus since Jul 202202351692Dormant
TARO-LISINOPRILStatus since May 202402294230Dormant
TARO-LISINOPRILStatus since May 202402294249Dormant
TARO-LISINOPRILStatus since May 202402294257Dormant
TARO-LOSARTANStatus since Mar 202302404451Dormant
TARO-LOSARTANStatus since Mar 202302404478Dormant
TARO-LOSARTANStatus since Mar 202302404486Dormant
TARO-MYCOPHENOLATEStatus since Oct 202102389754Approved
TARO-PANTOPRAZOLEStatus since Sep 202302305038Dormant
TARO-QUETIAPINEStatus since Dec 202102397099Dormant
TARO-QUETIAPINEStatus since Jul 202202397102Dormant
TARO-QUETIAPINEStatus since Jul 202202397110Dormant
TARO-QUETIAPINEStatus since Jul 202202397129Dormant
TARO-QUINAPRILStatus since Jun 202302299755Approved
TARO-QUINAPRILStatus since Jun 202302299763Approved
TARO-QUINAPRILStatus since Jun 202302299771Approved
TARO-QUINAPRILStatus since Jun 202302299798Approved
TARO-RABEPRAZOLE ECStatus since Jun 202302419785Approved
TARO-RABEPRAZOLE ECStatus since Jun 202302419793Approved
TARO-RAMIPRILStatus since Feb 202002425548Dormant
TARO-RISPERIDONEStatus since Jul 202502328305Dormant
TARO-RISPERIDONEStatus since Jul 202502328313Dormant
TARO-RISPERIDONEStatus since Jul 202502328321Dormant
TARO-RISPERIDONEStatus since Jul 202502328348Dormant
TARO-RISPERIDONEStatus since Jul 202502328364Dormant
TARO-RISPERIDONEStatus since Jul 202502328372Dormant
TARO-SILDENAFILStatus since Jul 202402383101Dormant
TARO-SILDENAFILStatus since Jul 202402383128Dormant
TARO-SILDENAFILStatus since Jul 202402383136Dormant
TARO-TADALAFILStatus since Mar 202402452081Dormant
TARO-TADALAFILStatus since Mar 202402452103Dormant
TARO-ZOPICLONEStatus since Jul 202202267918Dormant
TARO-ZOPICLONEStatus since Jul 202302267926Dormant
ACETAMINOPHEN ARTHRITIS PAINStatus since Jul 202502523124Cancelled Post Market
RBX-CELECOXIBStatus since Jul 202502420236Cancelled Pre Market
RBX-CELECOXIBStatus since Jul 202502420244Cancelled Pre Market
TARO-CELECOXIBStatus since Jul 202502412373Cancelled Post Market
TARO-CELECOXIBStatus since Jul 202502412381Cancelled Post Market
TARO-LETROZOLEStatus since Nov 202202372282Cancelled Post Market
TARO-RABEPRAZOLEStatus since Oct 202202298074Cancelled Post Market
TARO-RABEPRAZOLEStatus since Sep 202202298082Cancelled Post Market
TARO-TACROLIMUSStatus since Feb 202302453428Cancelled Pre Market
TARO-TELMISARTAN HCTZStatus since Jun 202202396238Cancelled Post Market
TARO-TELMISARTAN HCTZStatus since Jun 202202396246Cancelled Post Market

Natural health products

Active licences first, newest first.

NameNPNStatus
Taro-DocosanolLicensed May 202280118846Active
Hydrocortisone cream 1% with AloeLicensed Aug 201580063327Active
HydermLicensed Jan 201500716839Active
CortodermLicensed Jan 201500716693Active
Dermalac Lotion 12%Licensed Aug 200802238053Active
Dermalac Cream 12%Licensed Aug 200802239903Active
Hydrocortisone Cream 0.5 % USP with AloeLicensed Jul 200802243847Active
Hyderm Cream 0.5%Licensed Jul 200800716820Active
Cortoderm Ointment USP 0.5%Licensed Jul 200800716685Active

Notices of Compliance

Newest first.

  • SPC-ROSUVASTATINOctober 8, 2026 · NOC 38428 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-VISMODEGIBSeptember 28, 2026 · NOC 38362 · Abbreviated New Drug Submission (ANDS)
  • IBUPROFEN PLUS ACETAMINOPHENSeptember 11, 2026 · NOC 38269 · Abbreviated New Drug Submission (ANDS)
  • SPC-CLOPIDOGRELSeptember 9, 2026 · NOC 38246 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-METHYLPHENIDATE ERSeptember 2, 2026 · NOC 38214 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-DESVENLAFAXINESeptember 2, 2026 · NOC 38218 · Abbreviated New Drug Submission (ANDS)
  • SPC-ESTRADIOL 10August 11, 2026 · NOC 38097 · Abbreviated New Drug Submission (ANDS)
  • SPC-FENOFIBRATE EJuly 28, 2026 · NOC 38000 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CANDESARTANJuly 24, 2026 · NOC 37974 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-IRBESARTANJune 30, 2026 · NOC 37821 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-IMATINIBJune 24, 2026 · NOC 37778 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-GANIRELIXJune 22, 2026 · NOC 37748 · Abbreviated New Drug Submission (ANDS)
  • SPC-ATORVASTATINJune 13, 2026 · NOC 37897 · Abbreviated New Drug Submission (ANDS)
  • SPC-ESCITALOPRAMMarch 16, 2026 · NOC 37097 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-EZETIMIBEMarch 11, 2026 · NOC 37078 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-SIMVASTATINFebruary 16, 2026 · NOC 36918 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-AMPHETAMINE XRFebruary 9, 2026 · NOC 37038 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-MINOCYCLINEJanuary 13, 2026 · NOC 36721 · Abbreviated New Drug Submission (ANDS)
  • TARO-ESCITALOPRAMDecember 23, 2025 · NOC 36629 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-IRBESARTANDecember 17, 2025 · NOC 36600 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-FENOFIBRATE ENovember 7, 2025 · NOC 36350 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-CEFPROZILOctober 31, 2025 · NOC 36304 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-PANTOPRAZOLEOctober 9, 2025 · NOC 36135 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PANTOPRAZOLESeptember 3, 2025 · NOC 35941 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-BUPROPION XLSeptember 3, 2025 · NOC 35956 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-APIXABANAugust 5, 2025 · NOC 35831 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • RAN-CLARITHROMYCIN; TARO-CLARITHROMYCIN; TARO-CLARITHROMYCIN XLJuly 8, 2025 · NOC 35636 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-ROPINIROLEJune 26, 2025 · NOC 35585 · Abbreviated New Drug Submission (ANDS)
  • SPC-CEFPROZILJune 18, 2025 · NOC 35532 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-AMPHETAMINE XRJune 6, 2025 · NOC 35474 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SN-FENOFIBRATE EMay 28, 2025 · NOC 35436 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CEFPROZILMay 28, 2025 · NOC 35444 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ROSUVASTATINMay 7, 2025 · NOC 35373 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • SPC-MONTELUKASTApril 15, 2025 · NOC 35192 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-DOMPERIDONEApril 8, 2025 · NOC 35143 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-BUPROPION XLApril 4, 2025 · NOC 35131 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-METHYLPHENIDATE ERApril 2, 2025 · NOC 35116 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • DOMPERIDONEFebruary 4, 2025 · NOC 34786 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-DOMPERIDONEDecember 11, 2024 · NOC 34539 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-DONEPEZILNovember 19, 2024 · NOC 34403 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CLINDAMYCINNovember 15, 2024 · NOC 34405 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PREGABALINOctober 24, 2024 · NOC 34277 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ATENOLOLOctober 11, 2024 · NOC 34178 · Supplement to a New Drug Submission (SNDS)
  • DOMPERIDONESeptember 25, 2024 · NOC 34095 · Abbreviated New Drug Submission (ANDS)
  • TARO-RAMIPRILSeptember 20, 2024 · NOC 34055 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PRAVASTATINSeptember 3, 2024 · NOC 33919 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ROSUVASTATINAugust 29, 2024 · NOC 33888 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CANDESARTANAugust 22, 2024 · NOC 33853 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-EZETIMIBEAugust 19, 2024 · NOC 33830 · Abbreviated New Drug Submission (ANDS)
  • TARO-SILDENAFILJuly 24, 2024 · NOC 33702 · Abbreviated New Drug Submission (ANDS)
  • TARO-LISINOPRILMay 30, 2024 · NOC 33341 · Abbreviated New Drug Submission (ANDS)
  • TARO-ESCITALOPRAMMay 21, 2024 · NOC 33254 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-IRBESARTANMay 1, 2024 · NOC 33155 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-GLICLAZIDE MRApril 12, 2024 · NOC 33048 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-METHYLPHENIDATE ERMarch 15, 2024 · NOC 32893 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-TADALAFILMarch 8, 2024 · NOC 32846 · Abbreviated New Drug Submission (ANDS)
  • TARO-VALSARTANJanuary 17, 2024 · NOC 32534 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-SIMVASTATINJanuary 9, 2024 · NOC 32570 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ROSUVASTATINJanuary 9, 2024 · NOC 32571 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-AMLODIPINEDecember 27, 2023 · NOC 32422 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-RAMIPRIL HCTZNovember 30, 2023 · NOC 32225 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • PANTOPRAZOLENovember 30, 2023 · NOC 32257 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-VENLAFAXINE XRNovember 28, 2023 · NOC 32190 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-TRAMADOL/ACETNovember 22, 2023 · NOC 32159 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ATORVASTATINNovember 15, 2023 · NOC 32123 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-AMPHETAMINE XROctober 27, 2023 · NOC 31958 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • RBX-ATORVASTATINOctober 12, 2023 · NOC 31854 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PANTOPRAZOLEOctober 10, 2023 · NOC 31814 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PANTOPRAZOLESeptember 8, 2023 · NOC 31581 · Abbreviated New Drug Submission (ANDS)
  • TARO-PREGABALINSeptember 7, 2023 · NOC 31574 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-LANSOPRAZOLESeptember 1, 2023 · NOC 31551 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CLOPIDOGRELJuly 28, 2023 · NOC 31330 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ZOPICLONEJuly 10, 2023 · NOC 31178 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-METHYLPHENIDATE ERJune 28, 2023 · NOC 31080 · Abbreviated New Drug Submission (ANDS)
  • TARO-QUINAPRILJune 20, 2023 · NOC 31023 · Abbreviated New Drug Submission (ANDS)
  • TARO-RABEPRAZOLE ECJune 6, 2023 · NOC 30931 · Abbreviated New Drug Submission (ANDS)
  • TARO-VALSARTANMay 23, 2023 · NOC 30804 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CANDESARTANMay 12, 2023 · NOC 30739 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-IMATINIBApril 24, 2023 · NOC 30559 · Abbreviated New Drug Submission (ANDS)
  • TARO-IMATINIBApril 24, 2023 · NOC 30561 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-IRBESARTANApril 3, 2023 · NOC 30462 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-LOSARTANMarch 7, 2023 · NOC 30261 · Abbreviated New Drug Submission (ANDS)
  • RBX-CLOPIDOGRELFebruary 21, 2023 · NOC 30211 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CELECOXIBFebruary 7, 2023 · NOC 30069 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-FENOFIBRATE EFebruary 3, 2023 · NOC 30050 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ROSUVASTATINFebruary 1, 2023 · NOC 30025 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-CLOPIDOGRELJanuary 11, 2023 · NOC 29881 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-SIMVASTATINDecember 29, 2022 · NOC 29791 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • PANTOPRAZOLEDecember 16, 2022 · NOC 29714 · Abbreviated New Drug Submission (ANDS)
  • TARO-BUPROPION XLDecember 9, 2022 · NOC 29658 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PRAVASTATINDecember 9, 2022 · NOC 29667 · Abbreviated New Drug Submission (ANDS)
  • RBX-CLOPIDOGRELNovember 8, 2022 · NOC 29421 · Abbreviated New Drug Submission (ANDS)
  • RBX-CELECOXIBOctober 27, 2022 · NOC 29327 · Abbreviated New Drug Submission (ANDS)
  • TARO-VENLAFAXINE XROctober 27, 2022 · NOC 29332 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-PANTOPRAZOLESeptember 22, 2022 · NOC 29061 · Abbreviated New Drug Submission (ANDS)
  • TARO-APIXABANSeptember 20, 2022 · NOC 29018 · Abbreviated New Drug Submission (ANDS)
  • TARO-ATORVASTATINSeptember 12, 2022 · NOC 28954 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • TARO-ESCITALOPRAMSeptember 6, 2022 · NOC 28903 · Abbreviated New Drug Submission (ANDS)
  • TARO-IMIPENEM-CILASTATINJuly 22, 2022 · NOC 28642 · Supplement to an Abbreviated New Drug Submission (SANDS)
  • RBX-ATORVASTATINJune 28, 2022 · NOC 28486 · Supplement to an Abbreviated New Drug Submission (SANDS)

The latest 100 of 165.

Recalls and safety alerts that mention its products

Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.